Back to Journals » Drug Design, Development and Therapy » Volume 11

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

Total article views   HTML views PDF downloads Totals
17,788 Dovepress* 15,065+ 1,509 16,574
PubMed Central* 2,723 618 3,341
Totals 17,788 2,127 19,915
*Since 5 July 2017
Total mentioned Facebook Delicious Reddit Twitter Others
20 1 0 1 5 13

View citations on PubMed Central and Google Scholar